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To the Editor: 
We read with interest the study by Polkey and coworkers [1] showing the 
effectiveness of Tai Chi recreational exercise in a group of 120 COPD patients 
screened from a wide population. Two weeks after starting inhaled indacaterol 
150 mcg uid, naive COPD patients were randomized to receive either a standard 
pulmonary rehabilitation course (PR) or Tai Chi (TC) for 12 weeks. The primary 
end point was score change in the disease-specific Saint George Respiratory 
Questionnaire (SGRQ), with measurements taken from pre-post interventions and 
also 12 weeks later on. Authors found that TC was equivalent to PR for improving 
SGRQ in these patients. Moreover, a clinically significant difference in SGRQ 
emerged favouring TC 12-week after exercise cessation, thus suggesting that “Tai 
Chi is an appropriate substitute for PR”. 
On the basis of our current insights, the American Thoracic Society (ATS) and the 
European Respiratory Society (ERS) adopted in recent years a new and more 
structured definition of PR as “… a comprehensive intervention based on a 
thorough patient assessment followed by patient-tailored therapies, which 
include, but are not limited to, exercise training, education, and behaviour 
change, designed to improve the physical and psychological condition of people 
with chronic respiratory disease and to promote the long-term adherence of 
health-enhancing behaviours” [2]. This underlies two most important aspect of PR 
as a non-pharmacological intervention, namely the team-based work 
(multidisciplinary) and the individually tailored intervention with multiple 
activities. This recalls to our attention what is “pulmonary rehabilitation”, which is 
not any form of single physiotherapy intervention or leisure activity (including TC) 
where patients are asked to exercise irrespective of any physiological principles 
and (sometimes) outside the ideal setting. 
Overall, moderate to high levels of regular physical activity are associated with 
reduced lung function decline and exacerbation rates in patients with COPD [3] 
and may lower the risk of developing COPD among adult smokers [4]. The actual 
debate around the best and preferred form of exercise to be adopted to keep a 
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patient with COPD as active as possible, should not distract attention from which 
is the goal of PR as a  sophisticated  form of therapy. As a matter of fact, the 
study by Polkey et al. [1] indicates that patients in the PR group performed a mix 
of exercise training modalities rather than a formal course with multiple goals. For 
instance, the body mass index of the patients included was around 20-21 which 
claims for additional and structured forms of intervention (like nutritional 
support/advice) within a PR programme. Therefore, this study only seems to 
compare TC with exercise, but not with PR. Finally, no information on whether the 
exercise sessions in the two groups were attended was included in the paper, so  
that a potential Hawthorne effect [5] cannot be excluded, especially if referred to 
those patients performing TC. 
The population in the study (as in Table 1) indicates that the COPD included were 
of medium to high level of functional severity but with an apparently narrow 
range of dyspnea MRC-score and a good physical activity level (daily step count). 
This is consistent with the low existing relationship between lung function and 
physical performance status, which claims the priority to  immediate 
bronchodilation in symptomatic subjects before and over the possible and 
potential benefit of exercise, which is no alternative but an accessory to 
medication(s) [6]. 
Since the COPD population in the study was naïve to medication, the lack of a 
control arm using indacaterol alone may be criticized. Indeed, it is possible that 
improvements in SGRQ score were more likely to be induced by drug therapy 
thus leading to a “ceiling effect” which covered any difference between TC and 
PR. Rather interestingly introduction of indacaterol to naïve patients did not result 
in any significant improvement in lung function (e.g. FEV1), which might have 
been the case in moderate to severe patients [7], even more probable in 
individuals naïve to bronchodilators and/or unaware of their disease. 
With their conclusion (“Tai Chi is an appropriate substitute for PR”) authors 
essentially speculate that any recreational activity, like Tai Chi, may have the 
potential of a low-cost initial therapy among COPD. We  entirely catch the point 
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that every (potentially) useful intervention may be better than nothing, especially 
in those countries with difficult and inhomogeneous conditions like in China, with 
a 8.6% prevalence of COPD in an adult population of more than 1400 million 
people [8]. Clearly there is a role for alternative interventions to help patients 
with their disability in the long-term. In addition, it is very likely that Tai Chi can 
be learned easily by Chinese patients thanks to its diffusion in East Asia world 
region, thus making the technique more appealing both for patients and for 
clinicians in this geographical area. However, we suggest authors to be cautious 
when giving messages potentially able to neglect the relevance of medical 
therapy [6], which otherwise should be delivered to all symptomatic patients.  
 
 
 
 
  
Page 4 of 5
ScholarOne - http://mchelp.manuscriptcentral.com/gethelpnow/index.html - (434) 964-4100
CHEST
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
CONFIDENTIAL
References 
1. Polkey MI, Qiu ZH, Zhou L, Zhu MD, Wu YX, Chen YY, Ye SP, He YS, Jiang M, 
He BT, Mehta B, Zhong NS, Luo YM. Tai Chi and Pulmonary Rehabilitation 
Compared for Treatment-Naive Patients With COPD: A randomized controlled 
trial. Chest 2018; 153 (5): 1116-1124. 
2. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An 
official American Thoracic Society/European Respiratory Society statement: key 
concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 
2013; 188: e13–64. 
3. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces 
hospital admission and mortality in chronic obstructive pulmonary disease: a 
population-based cohort study. Thorax 2006; 61: 772–778. 
4. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies 
smoking-related lung function decline and reduces risk of Chronic Obstructive 
Pulmonary Disease. A population-based cohort study. Am J Respir Crit Care Med 
2007; 175: 458–463. 
5. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P; et al. The 
Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol 2007; 7: 
30. 
6. Global strategy for prevention, diagnosis and management of COPD. 
http://goldcopd.org/gold-reports/. Last accessed may 16, 2018. 
7. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer 
M, UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive 
pulmonary disease. N Engl J Med. 2008 Oct 9;359(15):1543-1554. 
8. Wang C, Xu J, Yang L. Prevalence and risk factors of chronic obstructive 
pulmonary disease in China (the China Pulmonary Health [CPH] study): a national 
cross-sectional study. Lancet 2018; 391: 1706-1717. 
 
Page 5 of 5
ScholarOne - http://mchelp.manuscriptcentral.com/gethelpnow/index.html - (434) 964-4100
CHEST
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
